Discrepancies in prevalence estimates in two national surveys for nonmedical use of a specific opioid product versus any prescription pain reliever

Discrepancies in prevalence estimates in two national surveys for nonmedical use of a specific opioid product versus any prescription pain reliever
复制标题

DOI:
10.1016/j.drugalcdep.2013.10.005
复制
发表时间:
2014-01-01
影响因子:
4.2
通讯作者:
Chilcoat, Howard D.
Chilcoat, Howard D.
中科院分区:
医学2区
文献类型:
--
作者:
Biondo, Gabriella;Chilcoat, Howard D.

文献摘要

被引文献

相似文献

背景资料:越来越需要了解处方止痛药作为一类以及特定阿片类药物的非医疗使用趋势。监测未来等调查和全国药物使用和健康调查是了解滥用处方药和非法药物趋势的重要工具。这份报告比较了这些调查之间的差异,一个特定的阿片类药物产品(羟考酮)相对于其他drugs.Methods:在过去一年中使用大麻,可卡因,羟考酮和任何处方止痛药的非医疗用途的趋势,估计为每个调查的五年期间(2005-2010年)为12年级的青少年。滥用羟考酮的非医疗止痛药用户的比例估计为each survey.Results:去年羟考酮非医疗使用的患病率是稳定的,随着时间的推移,两项调查,但2.5-3倍,在MTF相比,NSDUH。大麻和可卡因使用的流行趋势在各次调查中相似,尽管MTF中每种药物的流行率估计平均高出18%。相比之下,MTF中任何非医疗处方止痛药使用的患病率估计平均低15%。使用羟考酮的非医疗处方止痛药用户的比例为42%的MTF与19%in the NSDUH.Conclusion:非医疗使用羟考酮的患病率估计的调查之间的差异超过其他药物,指出视觉辅助工具和项目的重要性,用于衡量非医疗使用的特定产品。(C)2013作者由Elsevier爱尔兰有限公司出版。保留所有权利。
Background: There is a growing need to understand trends in nonmedical use of prescription pain relievers as a class, as well as specific opioid products. Surveys such as monitoring the future (MTF) and the National Survey on Drug Use and Health (NSDUH) are important tools for understanding trends in abuse of prescription and illegal drugs. This report compares discrepancies in prevalence between these surveys for a specific opioid product (oxycodone) relative to other drugs.Methods: Trends in past-year use of marijuana, cocaine, and nonmedical use of oxycodone and any prescription pain reliever were estimated for each survey for a five year period (2005-2010) for adolescents in 12th grade. The proportion of nonmedical pain reliever users who abused oxycodone was estimated for each survey.Results: Prevalence of past-year oxycodone nonmedical use was steady over time for both surveys, but 2.5-3 times higher in the MTF compared to the NSDUH. Trends in prevalence of marijuana and cocaine use were similar across surveys, although prevalence estimates for each were on average 18% higher in the MTF. In contrast, prevalence estimates for any nonmedical prescription pain reliever use were on average 15% lower in MTF. The proportion of nonmedical prescription pain reliever users who used oxycodone was 42% in the MTF versus 19% in the NSDUH.Conclusion: The discrepancy between surveys in prevalence estimates for nonmedical use of oxycodone exceed those for other drugs, pointing to the importance of visual aids and items used to measure the nonmedical use of specific products. (C) 2013 The Authors. Published by Elsevier Ireland Ltd. All rights reserved.